Association study between polymorphisms in glutathione-related genes and methamphetamine use disorder in a Japanese population

American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics
Tasuku HashimotoMasaomi Iyo

Abstract

Accumulating evidence suggests that oxidative stress plays a role in the mechanisms of action of methamphetamine (METH) in the brain. In the present study, we investigated the association between the genetic polymorphisms among glutathione (GSH)-related enzymes; glutathione S-transferases (GSTs) such as GSTT1 (Non-deletion/Null), GSTT2 (Met139Ile), GSTA1 (-69C/T), and GSTO1 (Ala140Asp); glutathione peroxidase 1 (GPX1) (Pro198Leu); and glutamate-cysteine ligase modifier (GCLM) subunit and METH use disorder in a Japanese population. Two hundred eighteen METH abusers and 233 healthy controls were enrolled in the study. There was a significant difference in GSTT1 genotype frequency between patients with METH psychosis and controls (P = 0.039, odds ratio: 1.52, 95% CI 1.03-2.24). Furthermore, the frequency (66.0%) of the GSTT1 null genotype among prolonged-type METH psychotic patients with spontaneous relapse was significantly higher (P = 0.025, odds ratio: 2.43, 95% CI 1.13-5.23) than that (44.4%) of transient-type METH psychotic patients without spontaneous relapse. However, there were no associations between the polymorphisms of other genes and METH abuse. The present study suggests that the polymorphism of the GSTT1 gene might b...Continue Reading

References

Jan 1, 1992·Schizophrenia Bulletin·M SatoT Hamamura
May 23, 1998·Biochimica Et Biophysica Acta·J Smythies, L Galzigna
Nov 18, 1998·Archives of General Psychiatry·K R MerikangasB J Rounsaville
Dec 29, 1998·The Journal of Nervous and Mental Disease·T R KostenG F Koob
Mar 18, 2000·Toxicology Letters·R C StrangeA A Fryer
Jul 6, 2000·Progress in Neurobiology·R Dringen
Aug 10, 2000·European Journal of Biochemistry·J B SchulzJ Dichgans
Sep 6, 2000·Pharmacology·J D Hayes, R C Strange
Feb 22, 2001·Journal of Neurochemistry·R E WhiteheadJ B Justice
Sep 21, 2001·Oral Oncology·T T SreelekhaM R Pillai
Jul 27, 2002·Trends in Genetics : TIG·George R UhlDaniel Naiman
Oct 2, 2003·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Jean Lud CadetXiaolin Deng
Mar 30, 2004·American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics·Hiroki KoizumiMasaomi Iyo
Jun 11, 2004·Journal of Neurochemistry·Anna MireckiStephen J Kish
Jun 17, 2004·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Kenji HashimotoMasaomi Iyo
Jun 24, 2004·Brain Research. Brain Research Reviews·Ulrich SchweizerNicolai E Savaskan
Nov 5, 2004·Alcohol and Alcoholism : International Journal of the Medical Council on Alcoholism·A M BrindA A Fryer
Nov 16, 2004·Annals of the New York Academy of Sciences·Hiroshi Ujike, Mitsumoto Sato
Feb 25, 2005·American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics·Tasuku HashimotoMasaomi Iyo
Apr 12, 2005·Annual Review of Pharmacology and Toxicology·John D HayesIan R Jowsey
Jul 5, 2005·Nature Reviews. Genetics·David GoldmanFrancesca Ducci
Jan 13, 2006·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Ikuko MiyazakiNorio Ogawa
Jun 9, 2006·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Cindy Achat-MendesYossef Itzhak

❮ Previous
Next ❯

Citations

Oct 30, 2015·Progress in Neurobiology·Yavuz AyhanMikhail V Pletnikov
Mar 1, 2010·Environmental Toxicology and Pharmacology·Yasunari MatsuzakaMinoru Kimura
Sep 25, 2008·Molecular Aspects of Medicine·Christopher C FranklinTerrance J Kavanagh
Feb 17, 2009·American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics·Chad A BousmanMing T Tsuang
Feb 1, 2011·Journal of Affective Disorders·Michael BerkOttar Bjerkeset
Mar 20, 2009·The Australian and New Zealand Journal of Psychiatry·Ju Lee OeiUNKNOWN NSW and ACT NAS Epidemiology Group
Feb 2, 2010·Annals of Human Biology·Renato PolimantiMaria Fuciarelli
Nov 21, 2020·Neuroscience and Biobehavioral Reviews·Alexandre A GuerinJee Hyun Kim

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics
Nobuhisa KanaharaKenji Hashimoto
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics
Tasuku HashimotoMasaomi Iyo
Proceedings of the National Academy of Sciences of the United States of America
René GysinKim Q Do
© 2021 Meta ULC. All rights reserved